The Indian stock markets saw an upswing fueled by the performance of banking stocks amid falling oil prices. The Sensex and Nifty enjoyed s...

Franklin India Small Cap Fund crossed Rs 14,000 crore in AUM, while a Rs 10,000 monthly SIP grew to nearly Rs 1.94 crore over 20 years. The...

Indian equity benchmarks recovered in Monday's session, breaking a four-day losing streak and reflecting positive global trends. The Sensex...

The government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

Indian equity markets rebounded on Monday, with the Nifty and Sensex rising 0.60% and 0.66%, respectively. ITC led the gainers, while HCL T...

Nifty has dipped significantly, nearing a critical support range of 22,000 to 22,600, catching the attention of traders looking for a poten...

Indian equities continued their downward trend due to rising global bond yields and high crude oil prices. The Nifty 50 fell by 198.50 poin...

External Affairs Minister S Jaishankar briefed a parliamentary panel on India’s multifaceted ties with Russia, including plans to expand tr...

Sebi has provided observations for the IPOs of Carlsberg India, Matangi Rubber, Ujin Pharma, and TMC Transformer. Carlsberg's filing is und...

In a significant move for India's market, Sebi has greenlit IPOs for Carlsberg's local entity, TMC Transformers, Ujin Pharma, and Matangi R...

India’s IPO pipeline expands as Sebi clears papers for Carlsberg India, Matangi Rubber, Ujin Pharma and TMC Transformer. The approvals come...

India’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...

Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...

The Indian stock market saw further declines as the Sensex dipped nearly 49 points while the Nifty sank around 96 points by session's end. ...

Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...